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Oligophrenin-1 (OPHN1) encodes a Rho-GTPase-activating protein (Rho-GAP) whose loss of function has been
associated with X-linked mental retardation (MR). The pathophysiological role of OPHN1, however, remains
poorly understood. Here we show that OPHN1 through its Rho-GAP activity plays a critical role in the activity-
dependent maturation and plasticity of excitatory synapses by controlling their structural and functional stability.
Synaptic activity through NMDA receptor activation drives OPHN1 into dendritic spines, where it forms
a complex with AMPA receptors, and selectively enhances AMPA-receptor-mediated synaptic transmission and
spine size by stabilizing synaptic AMPA receptors. Consequently, decreased or defective OPHN1 signaling
prevents glutamatergic synapse maturation and causes loss of synaptic structure, function, and plasticity. These
results imply that normal activity-driven glutamatergic synapse development is impaired by perturbation of
OPHN1 function. Thus, our findings link genetic deficits inOPHN1 to glutamatergic dysfunction and suggest that
defects in early circuitry development are an important contributory factor to this form of MR.
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The formation, maturation, and activity-dependent mod-
ification of the efficacy of glutamatergic synapses play
important roles in the development of neural circuits and
are critical for proper brain functions, such as information
processing and storage (Li and Sheng 2003; McAllister
2007; Citri and Malenka 2008). One key mechanism for
the regulation of synaptic strength, during both synaptic
development and plasticity, is the synaptic incorporation
and removal of AMPA-type glutamate receptors, the
principal receptors for fast excitatory neurotransmission
in the mammalian central nervous system (Shepherd
and Huganir 2007; Citri and Malenka 2008). In concur-
rence with an important role for these processes in
learning, memory, and cognition, accumulating evidence
suggests that impairments in synaptogenesis and/or
synaptic plasticity contribute to numerous mental and
neurological disorders, includingmental retardation (MR)
(Bagni and Greenough 2005; Chahrour and Zoghbi 2007;
Vaillend et al. 2008).
MR is generally defined as a global reduction in cog-
nitive abilities that manifests before the age of 18 (Chelly
et al. 2006). The causes of MR are extremely heteroge-
neous, including environmental factors as well as genetic
changes, such as chromosomal abnormalities and single-
gene mutations (Chelly et al. 2006; Vaillend et al. 2008).
Great progress has been made over recent years toward
the identification of MR genes, resulting in a list of more
than 280 genes (Inlow and Restifo 2004). A largely
remaining challenge, however, is to connect the genetic
causes of MR to processes that establish and/or modify
neuronal circuit function.
Several of the currently identified genes associated with
MR code for regulators and effectors of the Rho subfamily
of GTP-binding proteins (van Galen and Ramakers
2005; Nadif Kasri and Van Aelst 2008), which cycle be-
tween an inactive GDP-bound state and an active GTP-
bound state. Members of this family are key regulators
of the actin cytoskeleton and affect many aspects of
neuronal development (Govek et al. 2005). Their activity
is tightly controlled by dedicated guanine nucleotide ex-
change factors (GEFs), which promote GTP-loading, and
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GTPase-activating proteins (GAPs), which enhance hy-
drolysis of the bound GTP (Govek et al. 2005). Signifi-
cantly, mutations in genes encoding GAPs and GEFs, as
well as effectors of RhoGTPases, have been found to under-
lie various forms of MR (Nadif Kasri and Van Aelst 2008).
OPHN1, which encodes a Rho-GAP, was the first iden-
tified Rho-linked MR gene (Billuart et al. 1998). It was
initially identified by the analysis of a balanced trans-
location t(X;12) observed in a female patient with mild
MR (Bienvenu et al. 1997). Subsequent studies have re-
vealed the presence of OPHN1 mutations in families
with MR associated with cerebellar hypoplasia and lat-
eral ventricle enlargement (Tentler et al. 1999; Bergmann
et al. 2003; Philip et al. 2003; des Portes et al. 2004; Zanni
et al. 2005). AllOPHN1mutations identified to date have
been shown, or predicted, to result inOPHN1 loss of func-
tion (Zanni et al. 2005), and interestingly, inactivation of
ophn1 in mice has recently been demonstrated to recapit-
ulate some of the human phenotypes, such as behavioral,
social, and cognitive impairments (Khelfaoui et al. 2007).
The OPHN1 protein is highly expressed in the brain,
where it is found in neurons of all major regions, in-
cluding hippocampus and cortex, and it is present in both
the axon and dendrites of principal neurons (Govek et al.
2004). To date, however, the neuronal function of OPHN1
is largely elusive. Studies from our laboratory and others
have implicated OPHN1 in the regulation of spine mor-
phology of CA1 hippocampal neurons (Govek et al. 2004;
Khelfaoui et al. 2007), although it remains unclear
whether OPHN1 controls spine formation or mainte-
nance. Furthermore, the role of OPHN1 in the develop-
ment or function of glutamatergic synapses remains to be
elucidated.
Here, by temporally and spatiallymanipulatingOPHN1
gene expression, we demonstrate that post-synaptic
OPHN1 plays a key role in activity-dependent matura-
tion and plasticity of excitatory synapses by regulating
their structural and functional stability. Furthermore, we
show that OPHN1’s localization and function in excit-
atory synapses is dependent on synaptic activity and
NMDA receptor activation. Importantly, OPHN1 regu-
lates synaptic structure and function in a Rho-GAP
activity-dependent manner by controlling the stabiliza-
tion of AMPA receptors. Therefore, defective OPHN1
signaling results in destabilization of synaptic AMPA
receptors and spine structure, leading to impairment in
plasticity and eventually loss of spines and NMDA
receptors. Together, our results indicate that critical
levels of OPHN1 are necessary for proper activity-driven
glutamatergic synapse development and suggest a cellular
mechanism by which mutations in OPHN1 can contrib-
ute to the cognitive deficits observed inOPHN1 patients.
Results
OPHN1 regulates excitatory synaptic transmission
at hippocampal CA3–CA1 synapse
To assess whether post-synaptic OPHN1 is important
for synaptic function, we first examined the effects of
OPHN1 overexpression on synaptic transmission at the
hippocampal CA3–CA1 pathway. CA1 neurons in cul-
tured hippocampal slices were infected with a lentivirus
coexpressing wild-type OPHN1 (OPHN1-WT) and EGFP
(as a marker for infected cells) at 1 d in vitro (DIV). Seven
days post-infection, simultaneous recordings of evoked
excitatory post-synaptic currents (eEPSCs) from a CA1
pyramidal neuron overexpressing OPHN1-WT and an
adjacent noninfected neuron were performed. Overex-
pression of OPHN1-WT resulted in a potentiation of
AMPA receptor (AMPAR)-mediated transmission, but
not NMDA receptor (NMDAR)-mediated transmission
(Fig. 1A), indicating that ectopically expressed OPHN1 is
sufficient to enhance AMPAR-mediated transmission.
We next examined the function of endogenous OPHN1
by probing the effects of reduced OPHN1 expression on
synaptic transmission. To selectively reduce endogenous
OPHN1 protein levels in CA1 neurons, we used RNAi.
Lentiviral constructs were generated that coexpress EGFP
and shRNAs targeting either the translated (OPHN1#1)
or the 39-untranslated region (UTR, OPHN1#2) of rat
OPHN1 mRNA. Both OPHN1#1 and OPHN1#2 shRNA
drastically reduced endogenous OPHN1 protein levels in
hippocampal neurons, whereas a control shRNA (scr#1)
was ineffective (Supplemental Fig. S1).
CA1 neurons in hippocampal slices were then infected
with one of the above lentiviruses at 1 DIV and recorded
at 8 DIV. OPHN1#1 as well as OPHN1#2 shRNA signif-
icantly depressed both AMPAR- and NMDAR-mediated
transmission (Fig. 1B,C). In contrast, the control scr#1
shRNA did not affect AMPAR- or NMDAR-mediated
currents (Fig. 1D). To further test the specificity of
OPHN1 RNAi, we performed rescue experiments using
OPHN1 cDNA that lacks the 39-UTR and is therefore
resistant to OPHN1#2 shRNA-mediated RNAi. Neurons
were infected with a lentiviral vector that coexpresses
OPHN1#2 shRNA and RNAi-resistant OPHN1-WT-
EGFP. The levels of OPHN1-WT-EGFP in these neurons
were nearly similar to those of endogenous OPHN1 in
control cells (Supplemental Fig. S2A,B). Most impor-
tantly, these neurons did not show any defects in
AMPAR- or NMDAR-mediated transmission (Fig. 1E),
indicating that the observed effects of OPHN1 RNAi are
specific. Thus, endogenous OPHN1 function is required
for both AMPAR- and NMDAR-mediated transmission.
To determine whether OPHN1’s Rho-GAP activity,
which represses the RhoA/Rho-kinase pathway in hippo-
campal neurons (Supplemental Fig. S3; Govek et al. 2004),
is important for its function in synaptic transmission, we
generated an OPHN1 mutant, OPHN1-GAP, which vir-
tually lacks Rho-GAP activity (Supplemental Fig. S4).
This mutant was then tested for its ability to restore the
defects in AMPAR- and NMDAR-mediated transmission
of OPHN1#2 shRNA-expressing neurons. In contrast to
OPHN1-WT, coexpression of RNAi-resistant OPHN1-
GAP failed to rescue the OPHN1#2 shRNA-evoked
defects (Fig. 1F). OPHN1-GAP and OPHN1-WT were,
however, expressed at similar levels and displayed a
similar subcellular distribution (Supplemental Fig. S2).
These results indicate that OPHN1’s Rho-GAP activity is
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required for normal synaptic transmission at the CA3–
CA1 synapse. Consistent with this, ectopic expression
of OPHN1-GAP, in contrast to OPHN1-WT, failed to po-
tentiate AMPAR-mediated transmission (Supplemental
Fig. S5).
OPHN1 regulates glutamatergic synapse maturation
Since OPHN1-linked MR has been associated with de-
velopmental defects, we postulated that OPHN1 might
influence glutamatergic synaptic transmission by con-
trolling synapticmaturation that occurs during the period
that constructs are expressed. To test this, we examined
the effect of OPHN1 knockdown on miniature EPSCs
(mEPSCs), the responses to spontaneous release events at
single synapses, of CA1 pyramidal cells. Hippocampal
slices were infected with lentivirus expressingOPHN1#1
or OPHN1#2 shRNA at 1 DIV, and the frequency and
amplitude of mEPSCs were measured at 4 DIV and 8 DIV
(Fig. 2A–C). Normally, there is a significant increase in
mEPSC frequency and a small to no increase in mEPSC
amplitude, during early development of the CA3–CA1
synapse (Fig. 2A–C, control: 4 vs. 8 DIV; Barria and
Malinow 2005; Li et al. 2007). Strikingly, both OPHN1#1
and OPHN1#2 shRNA largely prevented the develop-
mental increase in mEPSC frequency (Fig. 2B) without
significantly influencing mEPSC amplitude (Fig. 2C). Of
note, the efficiency of OPHN1 knockdown was similar
at 4 DIV and 8 DIV (Fig. 2G). A change in frequency
usually reflects a change in the number of synaptic sites
or presynaptic release probability. We observed that
OPHN1 RNAi in post-synaptic cells did not affect
paired-pulse facilitation (PPF) (Supplemental Fig. S6),
a measurement of presynaptic release. Thus, our data
indicate that post-synaptic OPHN1 regulates excit-
atory synaptic maturation by controlling the number of
functional, AMPAR-containing, synapses. We also ex-
amined the impact of OPHN1 knockdown on inhibitory
(GABAergic) synapse maturation in CA1 pyramidal cells.
We found that OPHN1 knockdown during development
did not influence the frequency or amplitude of GABA
miniature inhibitory post-synaptic currents (mIPSCs)
(Fig. 2D–F). Together, our findings indicate that OPHN1
is critical for excitatory, but not inhibitory, synapse
maturation and that the effect of OPHN1 knockdown
on synaptic maturation occurs in a cell-autonomous
manner.
Activity-dependent regulation of OPHN1 function and
localization in excitatory synapses
Because knockdown of OPHN1 interferes with glutama-
tergic synapse maturation that is normally driven by
spontaneous activity and NMDAR activation (Zhu
et al. 2002; Barria and Malinow 2005), we reasoned that
activity blockade should occlude the effects of OPHN1
knockdown. To test this, we incubated organotypic
hippocampal slices in medium containing tetrodotoxin
(TTX), or high concentration of MgCl2, and then eva-
luated the effects of OPHN1 knockdown on synaptic
transmission in the CA3–CA1 synapse. TTX or high-
concentration MgCl2 treatment occluded the depression
effect of OPHN1 knockdown on both AMPAR- and
NMDAR-mediated transmission (Fig. 3A), indicating that
OPHN1 participates in activity-driven increase in gluta-
matergic function.
Figure 1. Post-synaptic OPHN1 regulates
synaptic transmission. (A–F, top panels)
Representative traces of EPSCs recorded
simultaneously from a pair of uninfected
neurons (control) and neurons infected with
indicated lentiviruses. EPSCs from both
60- and +40-mV holding potentials are
shown. Bars, 20 msec and 20 pA. (Bottom
panels) Quantification of the EPSCs medi-
ated by both AMPAR and NMDAR for each
experimental condition as indicated. The
EPSC amplitude was normalized to the
mean value of EPSCs from control neurons.
(A) OPHN1-WT: n = 12. (B) OPHN1#1: n =
10. (C)OPHN1#2: n = 12. (D) scr#1: n = 8. (E)
OPHN1#2 + OPHN1-WT: n = 12 pairs. (F)
OPHN1#2+OPHN1-GAP n = 11. Data are
shown as mean 6 SEM. (*) P < 0.05; (**) P <
0.01; (***) P < 0.005 by paired Student’s t-test.
OPHN1 controls synapse maturation and plasticity
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To further assess whether the function of OPHN1 in
the glutamatergic synapse depends on neuronal activity,
we examined whether treatment of slices with TTX, or
high concentration of MgCl2, prevents the potentiation
effect of ectopically expressed OPHN1 on AMPAR-
mediated transmission. We found that this is, indeed,
the case (Fig. 3B). Significantly, the NMDAR antagonist
2-amino-5-phosphonovaleric acid (APV) also blocked
the potentiation effect of OPHN1 (Fig. 3B), indicating
that NMDAR activation is required for OPHN1 synaptic
function.
Since TTX, MgCl2, or APV treatment did not affect the
global expression levels of endogenously or ectopically
expressed OPHN1 (Supplemental Fig. S7), we hypothe-
sized that normal spontaneous neuronal activity regu-
lates OPHN1’s synaptic distribution, thereby controlling
OPHN1 synaptic function. To test this, we taggedOPHN1
at its C terminus with EGFP and introduced OPHN1-
EGFP together with a red fluorescent protein, tDimer, as
a cellular marker, into CA1 cells in organotypic hippo-
campal slices by biolistic transfection. The subcellular
distribution of OPHN1 was examined by dual-channel
two-photon laser scanning microscopy (TPLSM). We
found that OPHN1-EGFP is more than twofold enriched
in the spines compared with dendritic shafts when slices
were maintained in normal media (Fig. 3C–F). However,
maintaining slices in TTX, or high concentration of
MgCl2, significantly reduced the enrichment of OPHN1
in spines (Fig. 3D–F). Also, maintaining slices in APV
largely prevented OPHN1 enrichment in spines (Fig.
3D–F), indicating that OPHN1 recruitment in spines
is dependent on NMDAR activation. Notably, a sim-
ilar activity-dependent redistribution was observed for
OPHN1-GAP (Supplemental Fig. S2C–E), indicating that
OPHN1’s Rho-GAP activity is not required for its re-
cruitment and that other domain(s) in OPHN1 and/or
interactions are involved. With regard to this, we found
that an OPHN1mutant lacking the N-terminally located
PH domain is absent in spines, and, in fact, only detect-
able in the nucleus (data not shown), implying that the
PH domain is important for OPHN1’s localization.
Together, our results support a model in which OPHN1
is recruited or stabilized in dendritic spines by spontane-
ous synaptic activity through the activation of NMDARs.
This activity-dependent regulation of OPHN1 is critical
for its role in controlling the functional maturation of
excitatory synapses and facilitating the strengthening of
synaptic transmission during synaptic development.
Figure 2. OPHN1 is critical for normal synaptic maturation. (A) Representative traces of excitatory miniature events recorded at 60
mV from uninfected neurons (control) and neurons expressingOPHN1#2 shRNA at different developmental stages (4 and 8 DIV). Bars, 2
sec and 20 pA. (B,C) Quantification of mEPSC frequency (B) and amplitude (C) for control and OPHN1#1 and OPHN1#2 shRNA-
expressing neurons at different developmental stages. (B) Four days in vitro: n = 18 cells for all groups; 8 DIV: control: n = 30 cells;
OPHN1#1: n = 21 cells;OPHN1#2: n = 30 cells. (C) Four days in vitro: n = 18 cells for all groups, 8 DIV: control: n = 30 cells;OPHN1#1:
n = 21 cells; OPHN1#2: n = 30 cells. (D) Representative traces of inhibitory miniature events recorded at +10 mV from uninfected
neurons (control) and neurons expressingOPHN1#2 shRNA at 8 DIV. Bars, 1 sec and 20 pA. (E,F) Quantification of mIPSC frequency (E)
and amplitude (F) from control and OPHN1#2 shRNA-expressing neurons at 8 DIV (n = 24 for both groups). Data are shown as mean 6
SEM. (*) P < 0.005 by Student’s t-test. (G) Immunoblot of extracts prepared from hippocampal neurons 4 and 8 d post-infection with
scr#1 (control) or OPHN1#2 shRNA probed with anti-OPHN1 and anti-ERK2 antibody as a loading control.
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OPHN1 is critical for stabilizing and maintaining
spine structure
Since OPHN1 is critical for the functional maturation of
synapses, we speculated that it might also be important
for their structural maturation, which involves growth
and stabilization of newly formed and existing spines. We
observed that acute knockdown of OPHN1—i.e., over
a period of 2 to 3 d—reduces spine length/size without
affecting spine density (Supplemental Fig. S8; Govek et al.
2004). Consistently, our electrophysiological data showed
that OPHN1 knockdown for 3 d has no effect on mEPSC
frequency (Fig. 2A,B, 4 DIV). However, knockdown of
OPHN1 during an extended period (for 7 d) led to a re-
duction in mEPSC frequency (Fig. 2A,B, 8 DIV), which
can be explained by a reduction in the number of
synapses. These findings suggested to us that OPHN1 is
likely required for the stabilization and growth of existing
synapses, rather than synaptogenesis.
If this is the case, knockdown of OPHN1 during an
extended period should eventually result in a reduction in
spine density, whereas ectopic expression of OPHN1
should not affect spine density, but increase spine size.
To test this, CA1 neurons in hippocampal slices were in-
fected with lentivirus coexpressing EGFP and OPHN1#2
shRNA, scr#1 shRNA, or no shRNA (control vector) at
1 DIV and imaged with TPLSM at 8 DIV. Spine density
and size on apical dendrites were measured. OPHN1#2
Figure 3. Spontaneous neuronal activity is important for OPHN1’s synaptic function and localization. (A, left panel) Representative
traces of EPSCs recorded simultaneously from a pair of uninfected neurons (control) and OPHN1#2 shRNA-expressing neurons under
the indicated conditions. (Right panel) Quantification of the EPSCs mediated by both AMPAR and NMDAR for each experimental
condition as indicated (untreated: n = 12 pairs; TTX: n = 10 pairs; MgCl2: n = 11 pairs). Data are shown as mean 6 SEM. (**) P < 0.01;
(***) P < 0.005, by paired Student’s t-test. (B, left panel) Representative traces of EPSCs recorded simultaneously from a pair of
uninfected neurons (control) and OPHN1-WT-expressing neurons under the indicated conditions. (Right panel) Quantification of the
EPSCs mediated by both AMPAR and NMDAR for each experimental condition as indicated (untreated: n = 12 pairs; TTX-treated: n =
12 pairs; MgCl2-treated: n = 10 pairs; APV-treated: n = 9 pairs). Data are shown as mean6 SEM. (*) P < 0.05 by paired Student’s t-test. (C)
Representative images of dendritic branches of a hippocampal CA1 pyramidal neuron cotransfected with OPHN1-EGFP (green) and
tDimer (red) maintained in normal media acquired with TPLSM. Bar, 10 mm. (D) Ratio images of cells expressing OPHN1-EGFP and
tDimer are shown under the indicated conditions. Blue depicts low OPHN1 density, and red depicts high density. Bar, 5 mm. (E)
Quantification of enrichment of OPHN1-EGFP in spines for each experimental condition as indicated (untreated: n = 7 cells; TTX-
treated: n = 8 cells; MgCl2-treated: n = 7 cells; APV-treated: n = 6 cells). (F) Cumulative distributions of enrichment of OPHN1-EGFP in
spines from the data plotted in E. Data are shown as mean 6 SEM. (**) P < 0.01 by the Kolmogorov-Smirnov test.
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shRNA, but not scr#1 shRNA, significantly reduced spine
density at 8 DIV when compared with control vector (Fig.
4A,B). OPHN1#2 shRNA also significantly decreased
spine size, although to a lesser extent (Fig. 4C). Impor-
tantly, coexpression of OPHN1-WT, but not OPHN1-
GAP, rescued the OPHN1#2 shRNA-evoked spine den-
sity and spine size phenotypes (Fig. 4A–C), implying that
OPHN1’s Rho-GAP activity is required for stabilizing/
maintaining spine structure. Consistent with this, ele-
vated and prolonged RhoA activity has been coupled to
reduced spine length, size, and density (Nakayama et al.
2000; Tashiro et al. 2000; Ryan et al. 2005; Sfakianos et al.
2007; Kang et al. 2009). Conversely, we found that over-
expression of OPHN1 did not alter spine density but
significantly increased spine size at 8 DIV (Fig. 4D–F). No
increase in spine size was seen when OPHN1-GAP was
ectopically expressed (Supplemental Fig. S9). These data
support the idea that OPHN1/RhoA-mediated signaling
is not critical for synaptogenesis, but rather stabilization
and growth of the existing synapses.
To substantiate OPHN1’s involvement in spine sta-
bilization/maintenance, we determined the number of
transient spines (lifetime <1 h) and of spine additions and
losses, the turnover rate (TOR), in neurons with and
without knockdown of OPHN1 during basal activity.
Specifically, CA1 neurons in hippocampal slices were
biolistically cotransfected with an OPHN1#2 or scr#1
shRNA-expressing construct and a tDimer expression
vector. At 4 and 8 d post-transfection, dynamics of spines
were monitored over a 2- to 3-h time period by 2-photon
imaging. Whereas in scr#1 shRNA-expressing neurons
the number of transient spines and the spine TOR
significantly decreased with development (Fig. 4G–I, 4
vs. 8 d), in OPHN1#2 shRNA-expressing neurons, both
the number of transient spines and spine TOR remained
elevated (Fig. 4G–I). These data imply that OPHN1
knockdown decreases spine stability during spontaneous
activity, which could underlie the observed arrest of
excitatory synaptic maturation.
Together, our findings strongly suggest that OPHN1/
RhoA-mediated signaling is critical for the stabilization
and maintenance of existing synapses, but is not suffi-
cient to promote new synapse formation.
OPHN1 is critical for structural and functional
synaptic plasticity
Since OPHN1 regulates spontaneous activity-dependent
plasticity, which shares many properties with a more
acute form of plasticity, long-term potentiation (LTP)
(Barria and Malinow 2005), we speculated that OPHN1
might also be important for LTP. To examine this,
OPHN1-WT-EGFP or OPHN1#2 shRNA, together with
tDimer, were expressed in CA1 neurons, and the slices
were incubated in elevated MgCl2 during the period
(4 d) that the constructs were expressed. This normal-
izes NMDA current between infected and uninfected
CA1 neurons, thereby precluding the effect of NMDAR
Figure 4. OPHN1 controls maintenance of spine
morphology. (A) Representative images of second-
ary apical dendrites from CA1 pyramidal neurons
infected at 1 DIV with indicated lentiviruses,
acquired with TPLSM at 8 DIV. Bars, 10 mm.
(B,C) Quantification of the spine density (B) and
spine size (C) for each experimental condition as
indicated (control: n = 9 cells; scr#1: n = 9 cells;
OPHN1#2: n = 9 cells; OPHN1#2 + OPHN1-WT:
n = 8 cells; OPHN1#2 + OPHN1-GAP: n = 8 cells).
(D) Representative images of secondary apical
dendrites from CA1 pyramidal neurons infected
at 1 DIV with lentivirus expressing EGFP only
(control), or OPHN1-WT and EGFP, acquired with
TPLSM at 8 DIV. Bars, 10 mm. (E,F) Quantification
of spine density (E) and size (F) for control neurons
and neurons expressing OPHN1-WT (n = 8 for all
conditions). (G) Time-lapse images of a dendrite
from a CA1 hippocampal neuron coexpressing
OPHN1#2shRNAandEGFP(at8dpost-transfection)
showing transient protrusions (arrowhead). Bar, 2
mm. (H,I) Fraction of transient spines (lifetime <1 h)
(H) and spine TOR (I) in scr#1 shRNA versus
OPHN1#2 shRNA-expressing neurons at 4 and 8
d post-transfection (n = 6 cells for all groups). Data
are shownasmean6SEM. (*)P<0.05; (**)P<0.01by
Student’s t-test.
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depression on synaptic plasticity (Fig. 3A,B). A chemical
LTP (cLTP) protocol was used to induce synaptic plastic-
ity (Kopec et al. 2006, 2007), and changes in individual
spines were monitored by TPLSM. To ensure the efficacy
of the cLTP protocol, we first tested the impact of cLTP on
neurons expressing the AMPAR subunit GluR1 tagged
with a pH-sensitive form of GFP (super ecliptic pHluorin;
SEP) and tDimer. Consistent with previous studies
(Kopec et al. 2006), we found that cLTP, which induces
transient synchronized bursting in organotypic slices
(Kopec et al. 2007), triggered a rapid and persistent
increase in spine size (Fig. 5A) and in the amount of
SEP-GluR1 on the spine surface in these neurons (Fig.
5A). Similarly, in neurons expressing OPHN1-EGFP, we
found that cLTP triggered a rapid and persistent increase
in spine size (Fig. 5B). Significantly, cLTP also induced
a rapid and persistent increase in the amount of OPHN1
in spines to an extent that is similar to the increase in
spine GluR1 during cLTP (Fig. 5B), further supporting the
idea that neuronal activity recruits OPHN1 into spines.
Figure 5. OPHN1 is critical for structural
and functional plasticity. (A,B, left) Images
of a CA1 pyramidal cell expressing tDimer
and SEP-GluR1 (A) or OPHN1-EGFP (B)
taken at 30 min (before) and +60 min
(after) relative to cLTP induction. Bar, 5
mm. (Right) Quantification of the inte-
grated red (volume) and green (SEP-GluR1
or OPHN1-EGFP) fluorescence for spines,
as well as the mean red (tDimer) and mean
green (SEP-GluR1 or OPHN1-EGFP) value
for dendrites at each time point during the
cLTP experiments. Each region of interest
is normalized to its value at the 5-min
time point. The black bar denotes cLTP
induction (n = 6 cells for all groups). (C)
Images of a CA1 pyramidal cell expressing
tDimer (control) or tDimer and OPHN1#2
shRNA taken at 30 min and +60 min
relative to cLTP induction. Bar, 5 mm. (D)
Quantification of the integrated red (vol-
ume) fluorescence for spines, as well as the
mean red (tDimer) value for dendrites at
each time point during the cLTP experi-
ments for each experimental condition as
indicated. Each region of interest is nor-
malized to its value at the 5 min time
point. The black bar denotes cLTP induc-
tion (n = 6 cells for all groups). (E) Images
of a CA1 pyramidal cell expressing
OPHN1#2 shRNA and tDimer, taken at
indicated time points, showing spine
size increase/decrease (arrow) andspine ap-
pearance/disappearance (arrowhead). Bar,
2 mm. (F) Fraction of transient spines (life-
time <1 h) after cLTP in control cells
versus OPHN1#2 shRNA-expressing neu-
rons (n = 6 cells for all groups). (G) Spine
TOR was measured before and after cLTP
in control and OPHN1#2 shRNA-express-
ing neurons at indicated time points (n = 6
cells for all groups). Data are shown as
mean 6 SEM. (*) P < 0.01 by Student’s
t-test. (H,I) LTP was induced in CA1 neu-
rons infected with indicated lentiviruses.
Slices were incubated in medium contain-
ing 10 mM MgCl2. (Top) Representative traces of AMPAR-mediated EPSCs. Traces are averaged for time points before (1) andafter (2)
LTP induction for the induced pathway (LTP) and control pathway (control). Bars, 25 msec and 10 pA. (Bottom) Normalized AMPAR-
mediated EPSCs before (1) and after (2) LTP induction for the induced pathway (closed symbols) andcontrol pathway (open symbols)
in neurons infected with lentiviruses, as indicated. (H) Control: n = 11; OPHN1#2: n = 12 reduced to 11; P < 0.05 measured between
35 and 40 min. (I) OPHN1#2+OPHN1-WT: n = 9; OPHN1#2+ OPHN1GAP: n = 10; P < 0.05 measured between 35 and 40 min by
a Mann-Whitney test.
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The increase of OPHN1 in spines is unlikely to be
a passive recruitment due to the increase in spine size,
since other proteins, such as NMDARs, do not increase in
spines during cLTP (Kopec et al. 2006). On the other hand,
expression of OPHN1#2 shRNA largely prevented the
spine size increase induced by cLTP (Fig. 5C,D), which,
importantly, could be restored by coexpression of RNAi-
resistant OPHN1-WT, but not OPHN1-GAP (Fig. 5D).
These data indicate that OPHN1 is required for cLTP-
induced spine size increase and that OPHN1’s Rho-GAP
activity is important for this event.
Interestingly, several observations in the cLTP experi-
ments further suggested that spines were less stable in
OPHN1 knockdown neurons. After cLTP, we observed
a larger fraction of transient spines (lifetime <1 h) in
OPHN1#2 shRNA-expressing neurons than in control
neurons (Fig. 5E,F). Furthermore, the turnover rate (TOR)
was significantly increased after knockdown of OPHN1,
both before and after cLTP (Fig. 5E,G). In OPHN1#2
shRNA-expressing neurons, the high TOR was due to
a nearly equal contribution of spine addition and loss,
resulting in little change in the total number of spines. In
control neurons, the TOR increased transiently after
cLTP (Fig. 5G), mostly due to spine additions. In sum-
mary, knockdown of OPHN1 prevents cLTP-induced
spine increase and results in a higher TOR and number
of transient spines after cLTP, implying that stabilization
of spine morphological changes may be impaired.
To investigate whether OPHN1 is also required for
the conventional, electrically induced LTP, we examined
LTP at the Schaffer collateral pathway in control and
OPHN1#2 shRNA-expressing CA1 neurons. To preclude
the effect of NMDAR depression on synaptic plasticity, we
incubated the brain slices in elevated MgCl2 during the
period that OPHN1#2 shRNA was expressed, which nor-
malized NMDA current between control and OPHN1#2
shRNA-expressing neurons (Fig. 3A). LTP-inducing stimuli
produced a robust and lasting potentiation in control,
uninfected, neurons (Fig. 5H). Interestingly, when LTP
was induced in neurons expressing OPHN1#2 shRNA,
we only observed an initial, transient, increase in synaptic
transmission, which returned to baseline levels 35–40 min
after induction (Fig. 5H). These results imply that OPHN1
knockdown significantly decreases LTP. The deficit in LTP
was rescued when RNAi-resistant OPHN1-WT, but not
OPHN1-GAP, was coexpressed with OPHN1#2 shRNA
(Fig. 5I), indicating that OPHN1’s Rho-GAP activity is
important for its effect on LTP.
OPHN1 controls synaptic function and structure
by stabilizing AMPA receptors
Several observations have indicated a strong positive
correlation between changes in spine size and synaptic
strength during LTP (Harris et al. 1992; Engert and
Bonhoeffer 1999; Matsuzaki et al. 2004; Kopec et al.
2006). How changes in spine structure and synaptic
strength are coordinated is currently under intense in-
vestigation. Our data implicate OPHN1 in the regulation
of both structure and function of excitatory synapses and
suggest that OPHN1 could be one of the factors that
coordinate structural and functional changes that occur
during synaptic development and plasticity.
Significantly, we found that OPHN1’s Rho-GAP activity,
which represses RhoA activity in neurons, is required for
maintaining spine structure, enhancing AMPAR-mediated
transmission, and structural and functional plasticity,
thus supporting the involvement of a RhoA-mediated
signaling pathway. A major downstream target of RhoA
and its regulators, including OPHN1, is the actin cyto-
skeleton (Govek et al. 2005). Actin remodeling, which
occurs in dendritic spines, drives changes in spine mor-
phology and is required for stable LTP, and, interestingly,
several recent observations pointed out that actin remod-
eling in the close proximity of AMPARs could be critical
for stabilizing AMPARs, thereby linking synaptic func-
tion and structure (for review, see Cingolani and Goda
2008). Hence, an intriguing question is whether OPHN1,
as a regulator of RhoA and the actin cytoskeleton, is in-
volved in the stabilization of AMPARs and in that way
controls and coordinates structural and functional changes.
As a first step toward addressing this question, we
investigated whether OPHN1 resides in the proximity of
AMPARs. In fact, given that OPHN1 translocates into
spines upon synaptic activity (Fig. 3C–F), where it enhan-
ces synaptic transmission, we reasoned that OPHN1
could potentially form a complex with AMPARs at the
synapse, thereby facilitating the local regulation of actin
dynamics and of synaptic AMPARs. To investigate this,
we performed coimmunoprecipitation experiments using
synaptosomes prepared from postnatal day 14 rat brains.
OPHN1 specifically coimmunoprecipitated with the
AMPAR subunits, GluR2 and GluR1, and vice versa,
GluR2 and GluR1 specifically coimmunoprecipitated
with OPHN1 (Fig. 6A,B). Furthermore, we found that
OPHN1 colocalized with both GluR1 and GluR2 in
spines (Fig. 6D). On the other hand, no interaction was
detected between OPHN1 and the NMDAR subunit NR1
(Fig. 6C), suggesting that OPHN1 is not a component
of NMDAR complexes. Thus, OPHN1 is coupled to
AMPARs at the synapse.
Next, we reasoned that if OPHN1 controls synaptic
function and structure by stabilizing AMPARs, then
stabilizing AMPARs should prevent the defects in syn-
aptic transmission, and in spine density/size, caused by
knockdown of OPHN1. To test this, we used a peptide
(GluR2-3Y) derived from the AMPARGluR2 C terminus,
which was described previously to stabilize AMPARs in
the synapse (Ahmadian et al. 2004). This peptide has
been demonstrated to block regulated AMPAR endocy-
tosis and LTD (Ahmadian et al. 2004; Brebner et al. 2005;
Fox et al. 2007; Wong et al. 2007) and to rescue the defect
in synaptic depression and spine loss resulting from
neuregulin-1/erbB4 loss of function (Li et al. 2007). It
remained, however, to be determined whether the
GluR2-3Y peptide also blocks naturally occurring
AMPAR endocytosis that underlies spontaneous activ-
ity-induced LTD (Zhu et al. 2002). To investigate this, we
incubated hippocampal brain slices with the GluR2-3Y
peptide for 4 d and then measured the frequency and
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amplitude of mEPSCs. The GluR2-3Y peptide, but not
the control GluR2-3A peptide, significantly increased
mEPSC frequency (Fig. 7A,B). No change in amplitude
was observed (Fig. 7C). These data imply that the GluR2-
3Y peptide blocks AMPAR endocytosis that is driven by
spontaneous activity. Consistent with this, we found
that neurons incubated for 4 d with the GluR2-3Y
peptide displayed an increase in spine density, a small
enlargement in spine size, and an increase in cell-surface
GluR2 expression levels compared with untreated con-
trol sister cultures (Supplemental Fig. S10).
We then infected slices with lentivirus expressing
OPHN1#2 shRNA at 1 DIV, incubated them with the
GluR2-3Y peptide from 4 DIV, and performed simulta-
neous recordings of eEPSCs from aCA1 pyramidal neuron
expressing OPHN1#2 shRNA and an adjacent nonin-
fected control neuron at 8 DIV. Strikingly, incubation
with the GluR2-3Y peptide for 4 d completely prevented
the effect of OPHN1 RNAi on AMPAR-mediated trans-
mission (Fig. 7D), and to some extent diminished the
effect of OPHN1 RNAi on NMDAR-mediated trans-
mission (Fig. 7D). Incubation of slices with the control
GluR2-3A peptide, which has no effect on AMPAR
stabilization, had no effect onOPHN1#2 shRNA-induced
synaptic depression (Fig. 7E), suggesting that the effects of
GluR2-3Y were specific.
Next, we examined whether incubation of slices with
GluR2-3Ypeptide could also prevent the effect of OPHN1
RNAi on spine density and size observed at 8 DIV.
Interestingly, incubation of slices with GluR2-3Y peptide
abolished the effect of OPHN1#2 shRNA on both spine
density and spine size (Fig. 7F,H). Given that the GluR2-
3Y peptide was applied at 4 DIV, when synapses are still
made (see above), these data imply that keeping AMPARs
at synapses prevents the destabilization of spine structure
caused by extended knockdown of OPHN1.
To further assess the involvement of OPHN1 in
AMPAR stabilization, we examined whether ectopic
OPHN1 expression influences NMDA-stimulated endo-
cytosis of the AMPAR GluR2 subunit. Application of
exogenous NMDA to hippocampal neurons has previ-
ously been shown to cause rapid endocytosis of GluR2
(Braithwaite et al. 2002). To quantify the degree of
NMDA-induced internalization of endogenous GluR2,
we used a biochemical method to cross-link surface-only
GluR2 (Hall and Soderling 1997). Hippocampal neurons
expressing OPHN1-WT and EGFP, or EGFP alone, were
left untreated or treated with NMDA, and subsequently
incubated with the membrane-impermeant cross-linking
reagent bis (sulfosuccinimidyl) suberate (BS3). Western
blotting with an anti-GluR2 antibody revealed that
NMDA treatment of control EGFP-expressing neurons,
as expected, decreased cell-surface GluR2 expression and
increased internalized GuR2 levels (Fig. 8A,B). The
NMDA-induced decrease in cell-surface GluR2 expres-
sion and increase in internal GluR2 levels were signifi-
cantly attenuated in neurons ectopically expressing
OPHN1-WT. Notably, these neurons in general displayed
relatively higher basal GluR2 surface levels than the
control neurons. These data imply that expression of
OPHN1 stabilizes AMPARs in the plasma membrane.
Since OPHN1 represses the RhoA/Rho-kinase pathway
in hippocampal neurons (Supplemental Figs. S3, S4;
Govek et al. 2004), we next examined the effect of
RhoA/Rho-kinase inhibition on NMDA-induced GluR2
endocytosis. We found that, akin to ectopic OPHN1
expression, treatment of neurons with the Rho-kinase
inhibitor, Y-27632, significantly attenuated the NMDA-
induced decrease in cell surface GluR2 expression and
increase in internal GluR2 levels (Fig. 8C,D). Thus, these
data are consistent with the idea that OPHN1—at least
in part by suppressing the RhoA/Rho-kinase pathway—
stabilizes a population of AMPARs in the synapse and
makes them resistant to regulated endocytosis.
Collectively, our results indicate that OPHN1-mediated
signaling controls synaptic function and structure by
regulating AMPAR stabilization in the synapse.
Discussion
Mutations in theOPHN1 gene have been shown to be the
cause of X-linked MR associated with cerebellar hypo-
plasia and enlargement of the ventricles (Tentler et al.
1999; Bergmann et al. 2003; Philip et al. 2003; des Portes
Figure 6. OPHN1 associates with AMPA receptor complexes.
(A) Synaptosmal fractions prepared from rat brains were in-
cubated with anti-GluR2 or anti-GluR1 antibody and immuno-
blotted with anti-OPHN1 and anti-GluR2 or anti-GluR1
antibody. Negative controls were IgG antibodies. (TL) Total
lysate. (B) Synaptosmal fractions were incubated with anti-
OPHN1 serum and immunoblotted with anti-GluR2, anti-
GluR1, and anti-OPHN1 antibody. Negative control was pre-
immune serum (p.i.). (C) Synaptosmal fractions were incubated
with anti-OPHN1 serum and immunoblotted with anti-NR1
and anti-OPHN1 antibody. Negative control was preimmune
serum (p.i.). (D) Colocalization of OPHN1 and AMPARs, GluR1
and GluR2, in dendritic spines. Cultured hippocampal neurons
expressing T7-OPHN1 (top panel) or OPHN1 (bottom panel)
were immunostained at 20 DIV with anti-mouse T7 and anti-
rabbit GluR1 (top panel) or anti-rabbit OPHN1 and anti-mouse
GluR2 (bottom panel) antibodies in membrane-permeabilizing
conditions. Bars, 5 mm.
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et al. 2004; Zanni et al. 2005). Thus far, however, the
underlying pathophysiology of cognitive dysfunction
resulting from mutations in OPHN1 remains largely
elusive. Our study provides a link between genetic
deficits in OPHN1, which are associated with OPHN1
loss of function, and glutamatergic dysfunction.
By temporally and spatially manipulating OPHN1 gene
expression at the hippocampal CA3–CA1 pathway, we
demonstrate that post-synaptic OPHN1 controls activity-
dependent maturation and plasticity of excitatory synap-
tic structure and function by regulating AMPAR stability.
In particular, OPHN1 is recruited or stabilized in den-
dritic spines by spontaneous activity through the activa-
tion of NMDARs. In turn, OPHN1 signaling regulates
activity-dependent AMPAR synaptic incorporation and
stabilization, as well as maintenance of spine structure,
thereby permitting synaptic maturation and plasticity.
Decreased or defective OPHN1 signaling therefore causes
destabilization of synaptic AMPARs and spine structure,
leading to impairment in plasticity and eventually loss of
spines/synapses and NMDARs. In view of these findings,
impaired OPHN1 function is likely to impact excitatory
circuit development by interfering with normal func-
tional and structural synaptic maturation. Thus, our
findings connect genetic perturbation of OPHN1 func-
tion to glutamatergic hypofunction and suggest that
defects in early circuitry development are an important
contributory factor to MR associated withOPHN1muta-
tions. Since mutations in other genes coding for regula-
tors or effectors of Rho GTPases (including MEGAP,
OCRL1, ARHGEF6, and PAK3) have been associated with
MR (Nadif Kasri and Van Aelst 2008), it will be interest-
ing to see whether they lead to a common dysfunction at
the level of synapse and/or circuitry development. The
role, however, of most of these Rho-linkedMR proteins in
synaptic function, plasticity, and development remains
largely unexplored (Endris et al. 2002; Lowe 2005; Node-
Langlois et al. 2006; but see Boda et al. 2004; Meng et al.
2005).
Our results unveil an interesting positive feedback
relationship between OPHN1 signaling and synaptic ac-
tivity, in that synaptic activity is required for OPHN1
signaling, and, in turn, OPHN1-mediated signaling en-
hances the efficacy of synaptic function. Such a positive
feedback relationship could play a key role during critical
periods of synapse development, with too little activity
leading to weakening of the synapse and threshold levels
of activity leading to its saturation. Clearly, other signal-
ing events besides those mediated by OPHN1 will
come into play to keep synaptic strength within a useful
Figure 7. OPHN1 regulates synaptic function and
structure by stabilizing AMPA receptors. (A) Represen-
tative traces of excitatory miniature events recorded at
60 mV from untreated neurons (control) and neurons
treated for 4 d with GluR2-3A or GluR2-3Y. Bars, 5 sec
and 20 pA. (B,C) Quantification of mEPSC frequency (B)
and amplitude (C) for control, GluR2-3A-treated, and
GluR2-3Y-treated neurons (control: n = 17 cells; GluR2-
3A: n = 16 cells; GluR2-3Y: n = 22 cells). (**) P < 0.01 by
Student’s t-test. (D,E, top panels) Representative traces of
EPSCs recorded simultaneously from a pair of uninfected
neurons (control) and OPHN1#2 shRNA-expressing neu-
rons treated with GluR2-3Y peptide (D) or GluR2-3A
peptide (E). Bars, 20 msec and 20 pA. (Bottom panel)
Quantification of the EPSCs mediated by both AMPAR
and NMDAR from pairs of neurons treated with GluR2-
3Y or GluR2-3A peptide. (D) GluR2-3Y: n = 15 pairs. (E)
GluR2-3A: n = 9 pairs. (F) Representative TPLSM images
of secondary apical dendrites from CA1 pyramidal neu-
rons expressing EGFP only (control) orOPHN1#2 shRNA
and EGFP (OPHN1#2) treated with GluR2-3Y peptide.
Bar, 10 mm. (G,H) Quantification of spine density (G) and
spine size (H) for control andOPHN1#2 shRNA-expressing
neurons treated with GluR2-3Ypeptide (n = 4 cells for both
groups). Data are shown as mean 6 SEM. (*) P < 0.05; (**)
P < 0.01 by paired Student’s t-test.
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dynamic range. The coupling between the function of
OPHN1 in excitatory synapses and synaptic activity also
suggests that the well-documented impact of experience
on synaptic function and structure is likely to involve
OPHN1-mediated signaling.
An important finding of this study is that activity-
dependent OPHN1 signaling controls synaptic structure
and function by regulating AMPAR stability, and that the
underlying mechanism involves OPHN1’s Rho-GAP ac-
tivity and a RhoA/Rho-kinase-mediated signaling path-
way. Indeed, we found that stabilizing AMPARs in the
synapse prevents both the defects in spine structure and
AMPAR-mediated transmission caused by knockdown of
OPHN1, and that, akin to ectopic expression of OPHN1-
WT, inhibition of the RhoA/Rho-kinase pathway attenu-
ates NMDA-stimulated AMPAR endocytosis. Moreover,
we observed that OPHN1’s Rho-GAP activity is im-
portant for maintaining spine structure, potentiating
AMPAR-mediated transmission, and structural and func-
tional plasticity.
In general, the biological functions of Rho-GAPs are
dependent on their subcellular localization (Govek et al.
2005); a local increase in their concentration and/or
activity upon an extracellular stimulus or cue can thereby
regulate the activity of Rho GTPases in a spatio-temporal
manner. We found that synaptic activity throughNMDAR
activation drives OPHN1 into dendritic spines, where it
forms a complex with AMPARs. Therefore, the local
increase in OPHN1 likely modulates RhoA and Rho-
kinase activities in the proximity of AMPARs. In this
regard, previous studies have demonstrated a decrease in
endogenous RhoA activity upon glutamate receptor acti-
vation (Van Aelst and Cline 2004; Kang et al. 2009). As
mentioned before, amain target of RhoA/Rho-kinase is the
actin cytoskeleton, and nascent actin filaments have been
implicated in the stabilization of AMPARs (for review, see
Cingolani and Goda 2008). Thus, a likely scenario is that
spine enriched OPHN1 by locally modulating RhoA/Rho-
kinase activities and actin dynamics (i.e., in the proximity
of AMPARs) contributes to the stabilization of AMPARs.
Given that actin remodeling has been suggested to be
required, but not sufficient on its own, to potentiate
synaptic transmission (Kim and Lisman 1999; Krucker
et al. 2000; Fukazawa et al. 2003), we do not exclude,
however, that actin-independent functions of the OPHN1/
RhoA pathway could also be involved in mediating
OPHN1 function. One such possibility could be a particu-
lar RhoA signaling pathway that regulates endocytic
trafficking (Govek et al. 2005). Also, OPHN1 through
interaction with AMPARs could potentially contribute to
the stabilization of AMPARs; this interaction, however, is
likely to involve other partners and/or post-translational
modifications.
In this study, we selectively manipulated OPHN1
levels in individual CA1 neurons in hippocampal slices
during a critical period of synapse development in order
to examine the function of OPHN1 in a cell-autonomous
manner. This is important because OPHN1 is expressed
both post- and presynaptically (Govek et al. 2004). In fact,
this could be one of the reasons why Khelfaoui et al.
(2007) failed to monitor a change in basal excitatory
transmission in the CA1 hippocampus of adult ophn1
global knockout mice; although, surprisingly, they did
observe a reduction in the number of mature spines.
Another complication is that they compared field EPSPs
across brain slices, without measuring input output
curves or measuring miniature EPSCs, which makes it
difficult to compare differences in basal transmission
between wild-type and ophn1 knockout mice. In our
study, comparisons of synaptic transmission between
wild-type neurons and neurons expressing OPHN1
shRNAs were performed simultaneously within the
same slice. Of note, Khelfaoui et al. (2007) did report
a decrease in PPF, a measurement of presynaptic release
in the OPHN1 knockout mice. We found that selective
knockdown of OPHN1 at the post-synaptic site does
not affect PPF, suggesting that the impaired PPF they
described is likely to result from presynaptic loss of
Figure 8. NMDA-induced endocytosis of
GluR2 is reduced in neurons ectopically
expressing OPHN1 and treated with Rho-
kinase inhibitor. (A) Surface and internal
GluR2 levels were determined by the BS3
cross-linking method. Hippocampal neurons
infected with lentiviral vector expressing
OPHN1-WT together with EGFP, or EGFP
alone, were left untreated () or were treated
(+) with NMDA and subsequently incubated
with BS3 (see the Supplemental Material).
Cell extracts were prepared and analyzed
with anti-GluR2, anti-OPHN1, and anti-g-
tubulin as a loading control. (B) Quantifica-
tion of surface and internal GluR2 levels
normalized to those of g-tubulin and then
normalized to the value of 1 for untreated
control vector-expressing cells. Data are
shown as mean 6 SEM, n = 3 independent experiments; (*) P < 0.05. (C,D) Same as A and B, except that uninfected hippocampal
neurons were used that were left untreated () or treated (+) with NMDA in the absence or presence of the Rho-kinase inhibitor Y-27632
(10 mM), and data were normalized to those of ERK2 and then normalized to the value of 1 for untreated cells.
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OPHN1 function, or alternatively is due to a compensa-
tory adaptation to the post-synaptic defect caused by very
long-term loss of OPHN1 in ophn1 knockout mice. Ex-
periments designed to selectively interfere with OPHN1
function at the presynaptic site will be needed to eluci-
date this.
In summary, our results reveal that activity-dependent
OPHN1-mediated signaling controls the stabilization of
AMPARs at the synapse and thus permits synaptic
plasticity and synaptic maturation. Therefore, loss of
OPHN1 (as is the case in individuals carrying OPHN1
mutations) leads to impaired synaptic development and
decreased glutamatergic function. Thus, our study pro-
vides a mechanism by which genetic deficits in OPHN1
that are associated with MR are linked to developmental
abnormalities and glutamatergic hypofunction. It further
highlights the concept that hypofunction of the glutama-
tergic system within specific circuits can contribute to
cognitive and neurodevelopmental disorders (Hsieh et al.
2006; Chahrour and Zoghbi 2007; Li et al. 2007). It should
be noted that also presynaptic loss of OPHN1 could
contribute to the pathogenesis of OPHN1-linked cogni-
tive impairment, as OPHN1 is present both post- and
presynaptically. The future elucidation of OPHN1’s pre-
synaptic function should shed further light on this.
Materials and methods
Hippocampal slice cultures, lentiviral infection, transfection,
and other treatments
Organotypic hippocampal slice cultureswere prepared from post-
natal day 6 or 7 rat pups as described (Govek et al. 2004). Slices
were infected after 1 d in culture (1 DIV) and used for electro-
physiology or imaging experiments at 4 or 8 DIV as indicated. To
infect hippocampal slice cultures, concentrated viral solution
was injected into the CA1 pyramidal cell layer using a Picosprit-
zer II (General Valve). For OPHN1 localization, time-lapse
imaging, and cLTP experiments, slices were biolistically trans-
fected at 7 DIV using a Helios Gene Gun (Bio-Rad) and imaged 4
and/or 8 d post-transfection.
For treatment with TTX, APV, high MgCl2 concentration, or
GluR2-3Y or 3A peptides, slices were infected with lentivirus at
day 1. At day 4, TTX (1 mM), APV (100 mM), MgCl2 (10 mM) or
the peptides (5 mM) were added to the medium. TTX, APV, or
peptides were replenished every 24 h. Recordings were made on
day 8. The sequences of GluR2-3Y and 3A are the same as
previously reported (Ahmadian et al. 2004). ATAT sequence was
fused to peptides to aid delivery into the cell. A dansyl group was
also included for visualization of the peptides (Li et al. 2007).
Accumulation of the peptides in neurons was readily detectable
by TPLSM at a wavelength of 720 nm (data not shown).
Electrophysiology
Whole-cell recordings were obtained with Axopatch-1D or Mul-
ticlamp 700B amplifiers (Axon Instruments). To monitor
OPHN1’s effects on synaptic transmission, slices were infected
with the respective indicated lentiviruses. Four days to 8 d later,
whole-cell recordings were obtained simultaneously from an
infected and an adjacent uninfected neuron in the CA1 region
under visual guidance using epifluorescence and transmitted
light illumination. The recording chamber was perfused with
artificial cerebrospinal fluid (ACSF) containing 119 mM NaCl,
2.5mMKCl, 4mMCaCl2, 4mMMgCl2, 26mMNaHCO3, 1mM
NaH2PO4, 11 mM glucose, 0.1 mM picrotoxin, and 4 mM
2-chloroadenosine (pH 7.4), and gassed with 5% CO2/95% O2.
Recordings were made at 27°C. Patch recording pipettes (3–5
MV) were filled with intracellular solution containing 115 mM
cesiummethanesulfonate, 20 mMCsCl, 10 mMHEPES, 2.5 mM
MgCl2, 4 mM Na2ATP, 0.4 mM Na3GTP, 10 mM sodium
phosphocreatine, and 0.6 mMEGTA (pH 7.25). Evoked responses
were induced using bipolar electrodes placed on Schaffer collat-
eral pathway. Responses were recorded at both 60 mV (for
AMPAR-mediated responses) and +40mV (for NMDAR-mediated
responses). NMDAR-mediated responses were quantified as the
mean between 60 and 65 msec after stimulation. All recordings
were done by stimulating two independent synaptic inputs;
results from each pathway were averaged and counted as n = 1.
Conventional LTP was induced by pairing presynaptic stimu-
lation at 3 Hz with depolarization of the post-synaptic neuron at
0 mV for 3 min; recordings were maintained for at least 40 min
after pairing. The EPSC amplitude was normalized to the average
baseline amplitude before pairing.
Spontaneous responses were recorded at60mV (mEPSC) and
+10 mV (mIPSC) in ACSF containing 2.5 mM CaCl2 and 1.2 mM
MgCl2 at 27°C. mEPSCs were recorded in the presence of 1 mM
TTX and 0.1 mM picrotoxin, whereas mIPSCs were recorded in
the presence of 10 mMCNQX and 100 mMAPV. Five to 10min of
recordings were analyzed from each cell. Data were acquired at 5
kHz, filtered at 2 kHz, and analyzed using the Mini Analysis
Program (Synaptosoft). All data are reported as mean 6 SEM.
Statistical significance was determined by the paired Student’s t-
test (for paired recordings) or the Mann-Whitney test (for un-
paired recordings). Significance was set to P < 0.05.
TPLSM and cLTP induction, image display,
and quantitative image analysis
These procedures were conducted largely as described in Kopec
et al. (2006); and see the Supplemental Material.
Other procedures
Generation of cDNA and shRNA constructs and methods for
immunofluorescence, transfection and infection of dissociated
hippocampal cultures, preparation of synaptosomes, coimmuno-
precipitation, RhoA activation, and AMPAR surface labeling are
described in the Supplemental Material.
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